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Abstract 
Basic calcium phosphate (BCP) crystals refer to a 
family of crystals including partially carbonate substi-
tuted hydroxyapatite, octacalcium phosphate, and trical-
cium phosphate. These crystals have been found in and 
around joints and have been associated with several 
forms of arthritis and periarthritis . Identification of 
BCP crystals remains problematic because of the lack of 
a simple, reliable analytic procedure. Methods currently 
in use include alizarin red S staining, labelled diphos-
phonate binding, scanning and transmission electron mi-
croscopy with energy dispersive X-ray microanalysis, X-
ray diffraction, and atomic force microscopy. Periar-
thropathies associated with BCP crystals include calcific 
tendinitis and bursitis. Intra-articular BCP crystal 
deposition is common in osteoarthritis, often found to-
gether with calcium pyrophosphate dihydrate crystals . 
Uncommon conditions in which BCP crystals are found 
include destructive shoulder arthropathies, acute inflam-
matory attacks of arthritis, and erosive arthritis. 
Secondary deposition of BCP crystals has been observed 
in chronic renal failure, in patients with "collagen 
vascular" diseases, followingneurologic injury and after 
local corticosteroid injection . 




Basic calcium phosphate (BCP) crystals, usually re-
ferred to as "apatite" or hydroxyapatite, actually consist 
of mixtures of partially carbonate-substituted hydroxy-
apatite, octacalcium phosphate, and tricalcium phosphate 
[39]. The latter two species may represent transition 
states leading to the final formation of hydroxyapatite. 
These crystals have now been associated with a variety 
of arthropathies yet their significance for the most part 
remains unclear. This review will discuss methods of 
BCP crystal identification and the periarthropathies and 
arthropathies associated with BCP deposition (Table 1). 
Table 1. Periarthropathies and arthropathies 
associated with basic calciwn phosphate (BCP) 
crystal deposition 




Intra-articular BCP arthropathies 
Osteoarthritis with BCP crystals 
Mixed crystal deposition (BCP and CPPD) 
Milwaukee shoulder/knee syndrome (Idiopathic 
destructive arthritis, cuff tear arthropathy) 
Acute inflammatory attacks 
Erosive polyarticular disease 
Secondary BCP crystal arthropathy/periarthropathy 
Chronic renal failure 
Calcinosis in connective tissue diseases 
Post neurologic injury calcification 
Post corticosteroid injection 
Miscellaneous 
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Methods of Detection of BCP Crystals 
BCP crystals are not birefringent. Thus, polarized 
light microscopy, which is quite sensitive and specific 
for identifying the other two most common "pathologi-
cal" crystals, monosodium urate monohydrate and cal-
cium pyrophosphate dihydrate (CPPD), is not useful for 
detecting BCP crystals. This is because individual BCP 
crystals, which are usually needle-shaped and less than 
0.1 µm long, cannot be resolved by light microscopy 
and are randomly oriented in the much larger aggregates 
(2-19 µm) in which they are usually found. Occasional-
ly, light microscopy will reveal laminated bodies re-
ferred to as "shiny coins" [37] but the usual appearance 
of these crystals is nondescript. 
The calcium dye, Alizarin red S, has been utilized 
by some investigators to identify BCP crystals [43]. 
Alizarin is highly sensitive but frequent false positive 
results suggest that it lacks sufficient specificity to 
qualify for routine identification of BCP crystals without 
some other type of confirmatory testing [2, 21] . 
We developed a semiquantitative binding assay for 
BCP crystals which utilires [14C] ethane-1-hydroxy-1,1-
diphosphonate (EHDP) [27]. This method is performed 
on a synovial fluid pellet resuspended in phosphate buf-
fered saline and the results are expressed as µg/ml of 
hydroxyapatite standard. The limit of sensitivity is 
approximately 2 µg/ml standard hydroxyapatite. 
Both scanning and transmission electron microscopy 
(SEM & TEM) with energy dispersive X-ray (EDX) mi-
croanalysis have been utilized to identify BCP crystals 
in synovial fluid pellets [29] . TEM with electron dif-
fraction is also effective [45]. For SEM the pellet is air 
dried on a carbon planchet and sputter coated with car-
bon. Crystals may be released from tissue specimens by 
collagenase digestion [25]. Specimens to be examined 
by TEM must be fixed in glutaraldehyde and processed 
by routine methods. Calcium:phosphorus molar ratios 
vary from 1.3-1.7:1 [29]. This is consistent with 
Fourier transform infrared spectroscopy (FTIR) which 
has shown that BCP crystal deposits consist of mixtures 
of hydroxyapatite, octacalcium phosphate, and rarely 
tricalcium phosphate crystals [39]. Amorphous calcium 
phosphates may be detected by EHDP binding and 
possibly FTIR. 
X-ray diffraction definitively identifies BCP crystals 
although the quantity of crystals necessary for analysis 
exceeds that required for the other techniques . 
Atomic force microscopy has been recently applied 
to the identification of synovial fluid microcrystals [4]. 
This technique is capable of achieving subnanometer 
resolution of crystal surface topology and measurement 
of lattice unit cell dimensions. 
These techniques have not been rigorously compared 
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and none has yet been shown to be clearly superior to 
the others. They are also unable to identify the site of 
origin of BCP crystals . Unfortunately, there is still no 
simple, readily available method to detect BCP crystals 
comparable to polarized light microscopy for mono-
sodium urate monohydrate and CPPD. 
Periarthropathies associated with BCP crystals 
Pathologic calcifications have been identified in a 
wide variety of periarticular sites, most commonly in 
bursae and tendons, especially near the sites of tendon 
insertions (entheses). For the most part, these appear to 
be isolated local dystrophic calcifications which are often 
asymptomatic. Mechanisms causing dystrophic calcifica-
tion remain obscure . Local tissue damage, age related 
changes and perhaps other factors may predispose to cal-
cification . In the rotator cuff, Uthoff and Sarkar [51] 
found that "primary" calcifications occurred in areas of 
metaplastic fibrocartilage accompanied by matrix vesi-
cles and crystals being phagocytosed by macrophages 
and giant cells . Others have not found chondrometa-
plasia and matrix vesicles but instead found calcifications 
in psammoma bodies and necrotic cells [22]. Dystrophic 
calcification occurs with normal calcium and phosphorus 
concentrations in contrast to metastatic calcification 
which occurs with disordered calcium or phosphorus 
metabolism. A few individuals have been described 
with multiple areas of dystrophic calcification suggesting 
the presence of a systemic disorder [37, 44]. Several 
families in which multiple members have had articular 
and peri-articular calcifications provide evidence that a 
heritable component may be present in some instances 
[7, 13, 23] . 
Many periarticular calcifications probably remain 
asymptomatic and may only be discovered fortuitously 
[5]. In some, though, dramatic inflammatory episodes 
may occur with severe pain , swelling and erythema re-
sembling gout. Asymptomatic deposits are usually gritty 
and hard, whereas some symptomatic deposits may be 
aspirable and appear as a whitish paste. Acute calcific 
tendinitis refers to inflammation of the tendon sheath 
along with BCP crystal deposition. The most common 
site of tendon calcification is the supraspinatus of the 
shoulder. Other common sites include the wrist, hip and 
knee but no site should be considered immune. This en-
tity differs from non-calcific tendinitis in that it is less 
likely to be related to trauma and inflammation tends to 
be more severe. Calcific bursitis refers to calcification 
and inflammation in one of the many cell lined bursal 
sacs which facilitate movement of tissues usually over 
bony prominences. One type, subacromial calcific bur-
sitis, is thought to occur when preformed, usually 
asymptomatic deposits of BCP crystals, rupture into the 
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bursa. 
Mechanisms of calcification remain obscure. Local 
tissue damage, age related changes, or hypoxia may pre-
dispose to calcification. These may somehow stimulate 
chondrocyte metaplasia in tendons with subsequent pro-
duction of calcifying matrix vesicles [51). 
Arthropathies Associated with 
Intra-articular BCP Deposition 
Although extra-articular BCP crystal deposition has 
long been recognized, the presence of BCP crystals 
within joints and synovial fluid was established more re-
cently by Dieppe et al. [10) and Schumacher et al. [48) 
using electron microscopy with EDX microanalysis. 
Several types of arthritis have now been associated 
with BCP crystals including osteoarthritis, destructive 
shoulder arthropathy, acute gout-like attacks, and erosive 
polyarthritis. BCP crystal deposition also occurs sec-
ondarily in chronic renal failure, in several of the con-
nective tissue diseases, rarely following severe neuro-
logic injury and intra-articular injection of crystalline 
corticosteroid preparations, and in other miscellaneous 
conditions. 
Several studies have suggested that the incidence of 
BCP crystals in synovial fluids of patients with knee os-
teoarthritis is between 30-60% [11, 18, 28). The radio-
graphic appearance of these joints does not differ from 
osteoarthritis although the amount of BCP crystals does 
correlate with the radiologic grade of degeneration [27, 
43). 
BCP crystals are frequently observed together with 
CPPD crystals and have been referred to as "mixed 
crystal deposition disease" [12) (Figure 1). In two se-
ries of patients with osteoarthritis of the knee, CPPD 
and BCP were found together in 29 % and 33 % of syno-
vial fluids whereas CPPD was found alone in 13 % and 
12% and BCP was found alone in 18% and 26% [18, 
28). Thus, BCP and CPPD seem to occur more often 
together than alone . This is surprising in light of the 
likelihood that BCP and CPPD form in different sites . 
BCP may emanate from exposed bone, metaplastic syno-
vium and cartilage [14) whereas CPPD crystals form 
within cartilage. Perhaps factors which favor crystal 
deposition in general affect both BCP and CPPD. Al-
though many studies have found an association between 
CPPD deposition and joint degeneration, most of these 
have not employed methodology which would have de-
tected BCP crystals. Whether or not CPPD crystal dep-
osition alone is associated with joint degeneration is still 
open to question. One study did find that CPPD crys-
tals, while associated with age, were not associated with 
joint degeneration [28). 
Acute attacks of arthritis have been observed occa-
sionally in radiographically normal joints and in joints 
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affected by osteoarthritis [17, 48). Synovial fluid dem-
onstrated hydroxyapatite crystals and elevated polymor-
phonuclear leucocyte counts . "Hydroxyapatite pseudo-
podagra" refers to gout-like attacks occurring in the first 
metatarsal phalangeal joint usually in young women 
associated with periarticular calcifications [16). 
A polyarticular, erosive form of arthritis associated 
with BCP crystals has also been described [47]. Pain 
and swelling were most prominent in the wrists, meta-
carpophalangeal joints and proximal interphalangeal 
joints. Massive articular calcification was observed 
radiographically and joint damage was progressive. 
"Milwaukee shoulder/knee syndrome" [38), also 
called "idiopathic destructive arthritis of the shoulder" 
[6] and "cuff tear arthropathy" [41), refers to a severe 
destructive arthropathy with large rotator cuff defects 
that is found mostly in elderly women. In a report of 30 
cases, the average age was 73 years (range 53-90) [24). 
The dominant side was the presenting joint in all except 
one case, but 60 % had bilateral involvement. Radio-
graphic evaluation showed rotator cuff defects in 46 of 
55 shoulders examined, marked destructive changes of 
the glenohumeraljoint, sclerosis, peri-articular calcifica-
tions in 55 % , and partial collapse of the humeral head 
in some . Synovial fluids show "non-inflammatory" leu-
cocyte counts, usually less than 1000/cmm with few 
polymorphonuclear cells. EHDP binding ( > 1 µg/ml 
hydroxyapatite standard) was found in 73 of 78 fluids. 
SEM demonstrated microspherioidal crystal masses with 
calcium to phosphorus molar ratios from 1. 3-1. 7 sug-
gesting BCP crystals (Figure 2) . Symptomatic knee in-
volvement was also found in 16 patients. Unexpectedly, 
lateral compartment disease (39 % ) exceeded medial 
compartment involvement (31 %). 
A number of secondary forms of BCP crysi.al-asso-
ciated arthropatbies have been described. Chronic renal 
failure predisposes to BCP crystal deposition but also to 
MSU , CPPD, calcium oxalate [30), aluminum phosphate 
[42), and 62 microglobulin amyloid deposition as well 
[3, 40). Symptomatic joints with BCP crystal deposition 
have had both normal and elevated synovial fluid leuco-
cyte counts [20, 53). 
Calcinosis occurs in several connective tissue dis-
orders including myositis, scleroderma, CREST syn-
drome, systemic lupus erythematosus, and overlap syn-
dromes [32, 34). Usually calcifications are found in 
skin and muscles but rarely bursal and intra-articular 
calcifications have been found. 
Occasionally, severe neurologic damage has been 
followed by heterotopic ossification in periarticular 
tissues that may mimic arthritis [19, 46). 
Intra-articular injection of the long lasting steroid 
triamcinolone hexacetonide has rarely been followed by 
periarticular calcification [33, 36). 
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Figure 1 (above). Scanning electron micrograph show-
ing mixed crystal deposition. Rhomboidal-shaped crys-
tals represent calcium pyrophosphate dihydrate and the 
irregular spheroids represent aggregates of basic calcium 
phosphate crystals . Bar = 10 µm. 
Figure 2 (below). Scanning electron micrograph show-
ing microspheroidal particles consisting of basic calcium 
phosphate crystals. Bar = 10 µm. 
----------------------------
Miscellaneous causes of BCP crystal deposition in-
clude vitamin D intoxication [35] and injection of olive 
oil into a knee [31]. BCP crystals have been identified 
in a few cases of rheumatoid arthritis with advanced 
joint destruction quite likely representing fragmentation 
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of bone. It is possible that very low levels of BCP 
crystals may occasionally be found in a variety of 
arthropathies. 
Significance of BCP Crystal Deposition 
The pathogenetic significance ofBCP crystal deposi-
tion remains uncertain. Synthetic BCP crystals clearly 
possess phlogistic potential [ 48], but in synovial fluid 
containing BCP crystals, leucocyte counts are usually not 
elevated [11]. Thus, BCP crystals do not generally in-
duce an inflammatory response of the type seen in at-
tacks of gout and pseudogout. The exceptions are the 
unusual gout-like episodes, "hydroxyapatite pseudo-
podagra" and calcific bursitis. Most likely, adsorbed 
proteins such as a2-HS glycoprotein play an important 
role in modulating crystal-cell interactions and resultant 
inflammation [50]. 
It is possible that BCP crystals may represent only 
an epiphenomenon. On the other hand, the association 
of crystals with advanced joint damage suggests that 
BCP crystals could amplify destructive processes within 
a joint. In osteoarthritis of the knee, severity of joint 
symptoms has been correlated with hydroxyapatite crys-
tals, other particles and the synovial fluid leucocyte 
count [49]. Biopsies of the synovium from joints with 
BCP deposition have shown patchy synovial lining cell 
proliferation suggesting low grade inflammation (26]. In 
vitro studies have shown that BCP crystals increase pro-
duction of prostaglandin E2, collagenase and other pro-
teases, and also increase mitogenesis in cultured synovial 
cells [8, 9]. Cartilaginous wear particles also increase 
neutral protease production [ 15]. Thus, low grade in-
flammatory changes could be mediated by BCP crystals, 
cartilage fragments, or possibly other factors. BCP 
crystals caused release of PGEi but not Il-1 from cul-
tured mouse macrophages [1] . Tumor necrosis factor 
but not II-I was increased in synovial fluids of osteo-
arthritic patients relative to rheumatoid arthritis (52]. 
This information is confusing because even higher levels 
of tumor necrosis factor were found in two other non-in-
flammatory joint fluids from patients without osteoarthri-
tis. Thus, the presence and role of cytokines in BCP re-
lated arthritis remains uncertain. Further studies will be 
necessary to elucidate the exact role of BCP crystals in 
arthritis. 
Treatment of BCP arthropathies is hampered by the 
poor understanding of mechanisms of calcification and 
the inability to interfere with that process in a selective 
fashion. Thus, treatment approaches have been largely 
symptomatic including the use of nonsteroidal anti-in-
flammatory agents, physical therapy, and joint aspiration 
with corticosteroid therapy. If severe joint damage has 
occurred, joint replacement surgery may be considered. 
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Discussion with Reviewers 
M. Doherty : In rapidly destructive joint disease asso-
ciated with plentiful BCP crystals, what is the likely site 
of origin of the crystals? Are they merely being shed 
from preformed deposits in capsule or tendon, are they 
predominantly coming from damaged subchondral bone, 
or is it possible that they form de novo in the articular 
space? 
Author: All the sites mentioned above are possible 
sources of BCP crystals. Unfortunately , there is very 
little data with which to answer the question . One of 
our early patients with Milwaukee Shoulder Syndrome 
bad an extensive synovectomy performed on her shoul-
der. Although an effusion returned postoperatively, the 
synovial contained no detectable BCP crystals suggesting 
that the synovium was the source of crystals in this case. 
M. Doherty: In addition to arthropathies where BCP 
crystals are found in high concentration, BCP can be de-
tected in many other joint conditions (e.g., rheumatoid, 
psoriatic arthropatby, etc.) and even in normal joint 
fluid. What comments can be made concerning the 
Arthropathies Associated with Basic Calcium Phosphate Crystals 
specificity of BCP for any particular joint disease or 
arthritic process? 
Author: Trace amounts of BCP crystals found in a va-
riety of arthropathies probably represent non-specific 
findings. Most likely, some threshold concentration of 
crystals needs to be exceeded in order to observe crys-
tal-induced effects. 
K.P.H. Pritzker: Is the binding assay specific? Is it 
too sensitive, i.e., does it pick up bound calcium and 
phosphorous, rather than mineralization? 
Author: The binding assay does not detect calcium 
pyrophosphate crystals. Amorphous calcium phosphates 
would potentially be detected by the binding assay ex-
cept that they are dissolved out from the synovial fluid 
pellet by washing and resuspending in phosphate buffer-
ed saline. 
P.A. Dieppe : Given the difficulty in identification and 
quantification, where do we go from here in trying to 
unravel the problem? 
Author: Unfortunately, there is no satisfactory animal 
model which reproduces the BCP associated arthro-
pathies that have been observed . Animal models such as 
the ank-ank mouse or the rat air pouch model may pro-
vide some useful information. Tissue/organ culture of 
synovium and cartilage from affected patients would also 
be interesting. In our laboratory, we are examining 
crystal cell interactions at a molecular biological level. 
P.A. Dieppe: Why is the shoulder so vulnerable to 
these disorders? 
Author : The rotator cuff is unique to the shoulder. 
This structure is susceptible to disorders which are not 
found in other joints including partial and complete 
tears, and probably ischemia of the supraspinatus 
tendon. 
P.A. Dieppe: Could you speculate on the role of BCP 
in joint destruction? Three positions have been taken: 
one that BCP has a major role in disease pathogenesis 
(McCarty and others), one that it is an irrelevant 
secondary phenomenon, and one that BCP may act as an 
amplification loop (Doherty, Dieppe and others). What 
do you think, and why? 
Author: All three scenarios may in fact have some va-
lidity. BCP crystals may be doing different things 
which may depend on the amount of crystals present, the 
size of the crystal masses, and probably other factors. 
BCP crystals have been detected at very low levels in 
some unrelated arthropathies in which they are most 
likely irrelevant. The difference between BCP crystals 
playing a "major role" versus "acting as an amplification 
loop" is seen as a semantic question representing degree 
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of affect. In acuted calcific bursitus and "hydroxyapatite 
pseudopodagra •, BCP seems to be playing a major role. 
In chronic conditions where several processes may be in 
play, there is no way to answer how much BCP contrib-
utes. Thus, BCP could be amplifying another process 
which is primary. 
K.P.H. Pritzker: It would be desirable to have a table 
outlining the sensitivity and specificity of each of the 
methods of detection of BCP crystals. 
Author: A direct comparison of the methods of detec-
tion of BCP crystals has not been completed. Thus, a 
meaningful table showing sensitivity and specificity of 
the methods is not possible. 
K.P.H. Pritzker: Regarding deposition of CPPD and 
basic calcium phosphate deposits: There is some 
contrary information in the literature [e.g., Pyro-
phosphate, phosphate ion interaction: Effects on calcium 
pyrophosphate and hydroxyapatite crystal formation in 
aqueous solutions. Pritzker et al. J. Rheumatology 
10(5):769-777, 1983). As well, the same group has 
found that the ionic conditions under which CPPD and 
BCP crystals can form are mutually exclusive [e.g., 
Calcium pyrophosphate crystal deposition in hyaline 
cartilage: Ultrastructural analysis and implications for 
pathogenesis. Pritzker KPH, et al. J. Rheumatology 
15:828-835, 1988). This would support the author's 
contention that the BCP is derived from fragmented bone 
or other oxygenous sources. 
Author: The gist of this comment appears to be that 
BCP and CPPD crystals do not form under the same 
ionic conditions. The finding of "mixed" crystals, 
simultaneous occurrence of BCP and CPPD in synovial 
fluid, does not require that they formed in the same 
locale. It seems quite possible that BCP and CPPD 
form in different sites and merely escape from those 
sites to be found together in synovial fluid. The fact 
that these crystals are found often together may suggest 
the presence of a nucleator or some other promoter of 
crystallization or the absence of an inhibitor of 
crystallization. 
C.R. Brown, Jr.: In clinical practice Alizarin Red is 
useful as a screening technique during synovial fluid 
analysis, followed by electron microscopy. The clinical 
use of Alizarin Red should be discussed. 
Author: Unless additional studies establish the utility of 
the Alizarin Red test alone, I believe it is dangerous to 
recommend it for routine screening of synovial fluids. 
